Biomarkers For Pancreatic Cancer To Be Tested In Multi-drug Collaborative Study
Executive Summary
Patient advocacy group is spearheading the genomics-driven trial, which will assess if stratification may finally be possible in pancreatic cancer.
You may also be interested in...
Master Protocols In Practice
Basket trials are building a path for tissue-agnostic drug development in oncology, and plans are proceeding for more master protocols in pediatric cancers, acute myeloid leukemia and pancreatic cancer.
AML Master Protocol For Precision Medicine Developed By Nonprofit And US FDA
Leukemia & Lymphoma Society worked with US FDA on umbrella trial strategy to accelerate development of new targeted therapies in molecularly-defined subsets of AML.
NewLink’s HyperAcute Program In Limbo After Pancreatic Trial Blow-Up
Company says it is evaluating what to do with its HyperAcute vaccine candidates in various tumor types, as focus shifts toward IDO programs.